These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30027775)

  • 1. Closed-loop insulin delivery: current status of diabetes technologies and future prospects.
    Majeed W; Thabit H
    Expert Rev Med Devices; 2018 Aug; 15(8):579-590. PubMed ID: 30027775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2014 Jun; 11(6):943-55. PubMed ID: 24749563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technology in the management of type 1 diabetes mellitus - current status and future prospects.
    Tauschmann M; Hovorka R
    Nat Rev Endocrinol; 2018 Aug; 14(8):464-475. PubMed ID: 29946127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closed-loop control in insulin pumps for type-1 diabetes mellitus: safety and efficacy.
    Fuchs J; Hovorka R
    Expert Rev Med Devices; 2020 Jul; 17(7):707-720. PubMed ID: 32569476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons.
    Thabit H; Hovorka R
    Expert Opin Drug Deliv; 2016; 13(3):389-400. PubMed ID: 26618219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances toward the implantable artificial pancreas for treatment of diabetes.
    Jaremko J; Rorstad O
    Diabetes Care; 1998 Mar; 21(3):444-50. PubMed ID: 9540030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-loop insulin delivery: update on the state of the field and emerging technologies.
    Ware J; Hovorka R
    Expert Rev Med Devices; 2022 Nov; 19(11):859-875. PubMed ID: 36331211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy.
    Renard E
    Curr Opin Pharmacol; 2002 Dec; 2(6):708-16. PubMed ID: 12482735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes.
    Ramli R; Reddy M; Oliver N
    Drugs; 2019 Jul; 79(10):1089-1101. PubMed ID: 31190305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological aspects of closed loop insulin delivery for type 1 diabetes.
    Uduku C; Oliver N
    Curr Opin Pharmacol; 2017 Oct; 36():29-33. PubMed ID: 28802779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating optimal utilisation of technology in type 1 diabetes mellitus from a clinical and health economic perspective: protocol for a systematic review.
    Pease A; Lo C; Earnest A; Liew D; Zoungas S
    Syst Rev; 2018 Mar; 7(1):44. PubMed ID: 29530081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-generation diabetes management: glucose sensor-augmented insulin pump therapy.
    Cengiz E; Sherr JL; Weinzimer SA; Tamborlane WV
    Expert Rev Med Devices; 2011 Jul; 8(4):449-58. PubMed ID: 21728731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Hybrid Closed-Loop System: Evolution and Practical Applications.
    Weaver KW; Hirsch IB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed-loop for type 1 diabetes - an introduction and appraisal for the generalist.
    Bally L; Thabit H; Hovorka R
    BMC Med; 2017 Jan; 15(1):14. PubMed ID: 28114938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.